Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING pathway
Year: 2025
Type: article
Abstract: Mitochondrial dysfunction is a hallmark of cellular senescence. Here, we investigated whether senescent cells release mitochondrial (mt)DNA into the extracellular space and its impact on innate immunity. We found that both primary senescent cells and tumor cells undergoing therapy-induced senescence actively released mtDNA into the extracellular environment. mtDNA released by senescent cells was packaged within extracellular vesicles and selectively transferred to polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in the tumor microenvironment. Upon uptake, extracellular mtDNA enhanced the immunosuppressive activity of PMN-MDSCs via cGAS-STING-NF-κB signaling, thereby promoting tumor progression. While STING activation directly induced NF-κB signaling, it also activated PKR-like endoplasmic reticulum kinase (PERK), which further amplified NF-κB activity, in PMN-MDSCs. mtDNA release from senescent cells was mediated by voltage-dependent anion channels (VDACs), and pharmacological inhibition of VDAC reduced extracellular mtDNA levels, reversed PMN-MDSC-driven immunosuppression, and enhanced chemotherapy efficacy in prostate cancer mouse models. These findings suggest that targeting mtDNA release could reprogram the immunosuppressive tumor microenvironment, improving therapeutic outcomes for chemotherapy-treated patients.
Source: Immunity
Authors: Ping Lai, Lei Liu, Nicolò Bancaro, Martina Troiani, Bianca Calì, Yuxin Li, Jingjing Chen, Prafull Kumar Singh, Rydell Alvarez Arzola, Giuseppe Attanasio, Nicolò Pernigoni, Emiliano Pasquini, Simone Mosole, Andrea Rinaldi, Jacopo Sgrignani, Shi Qiu, Pan Song, Yingrui Li, Maria Andrea Desbats, Azucena Rendón Ángel, Ricardo Pereira Mestre, Andrea Cavalli, Lucio Barile, Johann de Bono, Andrea Alimonti
Institutions: Institute of Oncology Research, Università della Svizzera italiana, University of Lausanne, Institute for Research in Biomedicine, Sichuan University, West China Hospital of Sichuan University, University of Padua, Veneto Institute of Molecular Medicine, Istituto Cardiocentro Ticino, Ente Ospedaliero Cantonale, Istituto Oncologico della Svizzera Italiana, Royal Marsden NHS Foundation Trust, Institute of Cancer Research
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $10,400
Funders: Fondazione AIRC per la ricerca sul cancro ETS, Portland Community Fund, Prostate Cancer Foundation, Novartis Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Novartis Stiftung für Medizinisch-Biologische Forschung, Associazione Italiana per la Ricerca sul Cancro, Swiss Cancer Research Foundation, Fondation ISREC, European Research Council
Awards: Development of senolytic therapies for chemotherapy-treated prostate cancer, G1589828271, G2799147712, G3048579308, Targeting cellular senescence in physiological, pathological and iatrogenic conditions, G5119037937, G6070636437, G6531787585, Excellence Grant – Development of senolytic therapies for chemotherapy-treated prostate cancer, Microbiota regulation of prostate cancer growth and metastatic dissemination, G7612119951
OpenAlex ID: W4409254393
